Application 085610
- Type
- ANDA
- Sponsor
- VITARINE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TRIPROLIDINE HYDROCHLORIDE | TRIPROLIDINE HYDROCHLORIDE | TABLET;ORAL | 2.5MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A085610-001 | TRIPROLIDINE HYDROCHLORIDE | TRIPROLIDINE HYDROCHLORIDE | 2.5MG | TABLET / ORAL | Approved before 1982 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A085610-001 | TRIPROLIDINE HYDROCHLORIDE | 2.5MG | TABLET / ORAL | Approved before 1982 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A085610-001 | TRIPROLIDINE HYDROCHLORIDE | 2.5MG | TABLET / ORAL | Approved before 1982 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A085610-001 | TRIPROLIDINE HYDROCHLORIDE | 2.5MG | TABLET / ORAL | Approved before 1982 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A085610-001 | TRIPROLIDINE HYDROCHLORIDE | 2.5MG | TABLET / ORAL | Approved before 1982 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| TRIPROLIDINE HYDROCHLORIDE | TRIPROLIDINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | 4eeffb6d-fc5e-48bc-95f6-ec4d5cb6e0d2 | 2026-08-10 | Warnings | TRIPROLIDINE HYDROCHLORIDE TRIPROLIDINE HYDROCHLORIDE |
| TRIPROLIDINE HYDROCHLORIDE | TRIPROLIDINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a9f01760-e335-4410-a9b8-8edce2841270 | 2026-08-10 | Warnings | TRIPROLIDINE HYDROCHLORIDE TRIPROLIDINE HYDROCHLORIDE |
| Childrens PediaClear PD | TRIPROLIDINE HYDROCHLORIDE | GM Pharmaceuticals, INC | f3ede5b7-1b0f-493a-b647-4459affc7e54 | 2025-10-03 | Warnings | TRIPROLIDINE HYDROCHLORIDE |
| HISTEX PD Drops New Formulation | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | 0c693f15-5d76-3dbf-e063-6294a90af9ac | 2025-01-08 | Warnings | TRIPROLIDINE HYDROCHLORIDE |
| HISTEX | TRIPROLIDINE HYDROCHLORIDE | Allegis Pharmaceuticals, LLC | cc466d33-cf3e-4f1c-a794-6d3d79903adf | 2024-01-08 | Warnings | TRIPROLIDINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.